BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16026325)

  • 1. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock.
    Evgenov OV; Liaudet L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):293-9. PubMed ID: 16026325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly (ADP-ribose) polymerase activation and circulatory shock.
    Szabó C
    Novartis Found Symp; 2007; 280():92-103; discussion 103-7, 160-4. PubMed ID: 17380790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(adenosine 5'-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness.
    Liaudet L
    Curr Opin Clin Nutr Metab Care; 2002 Mar; 5(2):175-84. PubMed ID: 11844985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
    Pacher P; Szabó C
    Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of poly(adenosine diphosphate-ribose) polymerase 1 in septic peritonitis.
    Liaudet L; Oddo M
    Curr Opin Crit Care; 2003 Apr; 9(2):152-8. PubMed ID: 12657979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
    Szabó G; Bährle S
    Curr Vasc Pharmacol; 2005 Jul; 3(3):215-20. PubMed ID: 16026318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K; Besson VC; Szabó C
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.
    Soriano FG; Virág L; Szabó C
    J Mol Med (Berl); 2001 Aug; 79(8):437-48. PubMed ID: 11511974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders.
    Chiarugi A; Moskowitz MA
    J Neurochem; 2003 Apr; 85(2):306-17. PubMed ID: 12675907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose) polymerase activation by reactive nitrogen species--relevance for the pathogenesis of inflammation.
    Szabó C
    Nitric Oxide; 2006 Mar; 14(2):169-79. PubMed ID: 16111903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation.
    Qin WD; Wei SJ; Wang XP; Wang J; Wang WK; Liu F; Gong L; Yan F; Zhang Y; Zhang M
    Biochim Biophys Acta; 2013 Jan; 1833(1):59-68. PubMed ID: 23085506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
    Szabó C; Dawson VL
    Trends Pharmacol Sci; 1998 Jul; 19(7):287-98. PubMed ID: 9703762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
    Virág L; Szabó C
    Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.
    Islam BU; Habib S; Ali SA; Moinuddin ; Ali A
    Cardiovasc Toxicol; 2017 Oct; 17(4):373-383. PubMed ID: 27990620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose) polymerase inhibitors.
    Southan GJ; Szabó C
    Curr Med Chem; 2003 Feb; 10(4):321-40. PubMed ID: 12570705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
    Kiss L; Szabó C
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation.
    Erdélyi K; Bakondi E; Gergely P; Szabó C; Virág L
    Cell Mol Life Sci; 2005 Apr; 62(7-8):751-9. PubMed ID: 15868400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach.
    Perrotta I; Brunelli E; Sciangula A; Conforti F; Perrotta E; Tripepi S; Donato G; Cassese M
    Cardiovasc Pathol; 2011; 20(4):195-203. PubMed ID: 20619687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.